Virtual Demonstrations
Request a Quote

News & Events

I value being part of the largest and fastest growing user community of its kind in the world

Instem Client

Bookmark and Share

WuXi AppTec Purchases Instem’s Provantis™ Software for Toxicology Facility in China

CONSHOHOCKEN, PA - (BUSINESS WIRE) - August 5, 2009 - - Instem, a leading provider of early drug development software solutions, announced today that WuXi AppTec (WuXi) has purchased the Provantis™ preclinical solution for its world-class facility in Suzhou, China. Wuxi will be deploying integrated modules for its General Toxicology, Clinical Pathology, Pathology and Formulations Departments for test item control.

Provantis™ is a modern, fully integrated software system for single users and global organizations engaged in non-clinical evaluation studies. Orchestrating every facet of preclinical drug safety assessment, Provantis™ streamlines processes and workflows with straightforward, intuitive functionality for simple or complex studies within a GLP or non-GLP environment. Provantis™ will be installed in WuXi’s newly constructed, 314,000 square-feet toxicology facility in Suzhou, the largest of its kind in China. The facility will follow the “Guiding Principles in the Use of Animals in Toxicology” and will operate to AAALAC standards.

WuXi’s purchase of Provantis™ supports its ongoing commitment to providing the highest-quality services to help the world’s leading pharmaceutical, biotechnology and medical device companies shorten the time and lower the cost of R&D. Benefits of the Provantis™ software system include:

  • Time savings and increased study throughput
  • Improved quality via 21 CFR Part 11 compliance
  • Greater use of valuable resources
  • Faster response times to customer requests
  • Significant reduction of overhead costs for quality assurance
  • Overall increased capability to perform more studies

About WuXi AppTec and WuXi PharmaTech
WuXi PharmaTech (NYSE: WX) is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides a broad and integrated portfolio of laboratory and manufacturing services throughout the pharmaceutical and medical device R&D process. WuXi PharmaTech's operating subsidiaries are known as WuXi AppTec. For more information, please visit: http://www.wuxiapptec.com.

About Instem
Instem is a world-leading information solutions provider for the Life Sciences - accelerating drug and chemical development by increasing client productivity and enhancing the processes that lead to safer, more effective products. In addition to highly focused departmental and scientific solutions, Instem provides a range of Business Intelligence, Planning, Workflow Management, Dosage Formulation, Document Management and Report Compilation applications.

Press Contact:

Instem
Automate. Accelerate. Discover.
Gary E. Mitchell
Tel: 610.941.0990
Email: gary.mitchell@instem.com